INS and Hyperglycemia: The dysfunction of pancreatic β-cells causes a reduction in insulin secretion that results in the inability to maintain physiological glucose levels, while IR promotes the production of glucose in the liver and decreases glucose uptake in muscle, liver, and adipose tissue, thus creating a flawed feedback loop between insulin action and secretion, leading to hyperglycemia [10,11].